Learn More
OBJECTIVE To assess the efficacy and safety of golimumab in patients with active psoriatic arthritis (PsA). METHODS Adult patients with PsA who had at least 3 swollen and 3 tender joints and active(More)
BACKGROUND Ustekinumab, a human monoclonal antibody against interleukins 12 and 23, has shown therapeutic potential for psoriasis. This study assessed the efficacy and safety of ustekinumab in(More)
BACKGROUND In previous phase II studies, alefacept significantly improved psoriasis and was well tolerated. The clinical response to alefacept was durable. OBJECTIVE Our purpose was to further(More)